Page last updated: 2024-10-18

dalteparin and Ureteral Diseases

dalteparin has been researched along with Ureteral Diseases in 2 studies

Dalteparin: A low-molecular-weight fragment of heparin, prepared by nitrous acid depolymerization of porcine mucosal heparin. The mean molecular weight is 4000-6000 daltons. It is used therapeutically as an antithrombotic agent. (From Merck Index, 11th ed)

Ureteral Diseases: Pathological processes involving the URETERS.

Research Excerpts

ExcerptRelevanceReference
"The management of a patient with venous thrombosis with perinephric hematoma post renal biopsy can be difficult if occurred."1.72Double trouble - management of perinephric hematoma and renal vein thrombosis post percutaneous renal biopsy. ( Daud, MAM; Kamarudin, MI; Nadarajan, C, 2022)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (50.00)24.3611
2020's1 (50.00)2.80

Authors

AuthorsStudies
Kamarudin, MI1
Nadarajan, C1
Daud, MAM1
Westerman, ME1
Scales, JA1
Sharma, V1
Gearman, DJ1
Ingimarsson, JP1
Krambeck, AE1

Other Studies

2 other studies available for dalteparin and Ureteral Diseases

ArticleYear
Double trouble - management of perinephric hematoma and renal vein thrombosis post percutaneous renal biopsy.
    BMC nephrology, 2022, 09-09, Volume: 23, Issue:1

    Topics: Adult; Biopsy; Enoxaparin; Gastrointestinal Hemorrhage; Hematoma; Hematuria; Humans; Kidney Diseases

2022
The Effect of Anticoagulation on Bleeding-related Complications Following Ureteroscopy.
    Urology, 2017, Volume: 100

    Topics: Aged; Anticoagulants; Blood Loss, Surgical; Drug Administration Schedule; Enoxaparin; Female; Humans

2017